On the use of chloroquine for chikungunya

Lancet Infectious Diseases

Volumn 7, Issue 10, 2007, Pages 633-

  Savarino, Andrea ^a   Cauda, Roberto ^b   Cassone, Antonio ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE;

ANTIVIRAL ACTIVITY; ARTHRALGIA; CHIKUNGUNYA ALPHAVIRUS; DRUG EFFICACY; DRUG USE; HEALTH CARE POLICY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LETTER; PRIORITY JOURNAL; VIRUS INFECTION;

ALPHAVIRUS INFECTIONS; ANTIRHEUMATIC AGENTS; ARTHRALGIA; CHIKUNGUNYA VIRUS; CHLOROQUINE; HUMANS; TREATMENT FAILURE;

EID: 34548828524     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(07)70217-7     Document Type: Letter

References (12)

1. Pialoux G., Gaüzère B., Jauréguiberry S., and Strobel M. Chikungunya, an epidemic arbovirosis. Lancet Infect Dis 7 (2007) 319-327
2. Savarino A., Di Trani L., Donatelli I., Cauda R., and Cassone A. New insights into the antiviral effects of chloroquine. Lancet Infect Dis 6 (2006) 67-69
3. Savarino A., Boelaert J., Cassone A., Majori G., and Cauda R. Effects of chloroquine on viral infections: an old drug against today's diseases. Lancet Infect Dis 3 (2003) 722-727
4. Savarino A., Lucia M., Rastrelli E., et al. Anti-HIV effects of chloroquine: inhibition of viral particle glycosylation and synergism with protease inhibitors. J Acquir Immune Defic Syndr 35 (2004) 223-232
5. Di Trani L., Savarino A., Campitelli L., et al. Different pH requirements are associated with divergent inhibitory effects of chloroquine on human and avian influenza A viruses. Virol J 4 (2007) 39
6. Savarino A., Lucia M., Giordano F., and Cauda R. Risks and benefits of chloroquine use in anticancer strategies. Lancet Oncol 7 (2006) 792-793
7. Naarding M., Baan E., Pollakis G., and Paxton W. Effect of chloroquine on reducing HIV-1 replication in vitro and the DC-SIGN mediated transfer of virus to CD4+ T-lymphocytes. Retrovirology 4 (2007) 6
8. Keyaerts E., Vijgen L., Maes P., Neyts J., and Van Ranst M. In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine. Biochem Biophys Res Commun 323 (2004) 264-268
9. Ooi E., Chew J., Loh J., and Chua R. In vitro inhibition of human influenza A virus replication by chloroquine. Virol J 3 (2006) 39
10. Sundberg A., and Steffen A. Enhancing the effect of radionuclide tumor targeting, using lysosomotropic weak bases. Int J Radiat Oncol Biol Phys 67 (2007) 279-287
11. The ClinicalTrials.Gov database. CuraChik: a trial of the efficacy and safety of chloroquine as therapeutic treatment of chikungunya disease http://clinicaltrials.gov/ct/show/NCT00391313;jsessionid=F91ADE5077910A5240B7AA9AA7666FA8?order=1 (accessed Aug 9, 2007).
12. Savarino A., Lucia M., ter Heine R., et al. Quinoline antimalarials as investigational drugs for HIV-1/AIDS: in vitro effects on HIV-1 replication, HIV-1 response to antiretroviral drugs, and intracellular antiretroviral drug concentrations. Drug Dev Res 67 (2006) 806-817